(Q64377180)
Statements
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer (English)
John G Page
Baohong Tian
Karen Schweikart
Joseph Tomaszewski
Ray Harris
Trevor Broadt
Judith Polley-Nelson
Patricia E Noker
Minghui Wang
Sharmila Makhija
Rose Aurigemma
Ronald D Alvarez
David T Curiel
389.e1-9; discussion 389.e9-10